Testing effectiveness (Phase 2)Study completedNCT00734734
What this trial is testing
Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009
Who this might be right for
Interpandemic Influenza
Novartis Vaccines 64